Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 270,200 | 340,800 | 311,100 | 368,000 | 352,600 |
| Marketable Securities | 394,700 | 370,500 | 454,800 | 516,900 | 521,100 |
| Receivables | 263,500 | 185,500 | 163,800 | 158,500 | 147,800 |
| Inventories | 29,000 | 30,500 | 25,500 | 28,300 | 30,100 |
| Other current assets | 60,800 | 45,500 | 50,500 | 38,400 | 33,800 |
| TOTAL | $1,018,200 | $972,800 | $1,005,700 | $1,110,100 | $1,085,400 |
| Non-Current Assets | |||||
| PPE Net | 63,900 | 58,600 | 51,100 | 50,000 | 45,300 |
| Investments And Advances | 632,300 | 624,400 | 549,000 | 376,700 | 288,500 |
| Other Non-Current Assets | 430,100 | 416,700 | 411,500 | 419,600 | 427,200 |
| TOTAL | $1,126,300 | $1,099,700 | $1,011,600 | $846,300 | $761,000 |
| Total Assets | $2,144,500 | $2,072,500 | $2,017,300 | $1,956,400 | $1,846,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 235,900 | 225,800 | 205,900 | 190,900 | 171,900 |
| Other current liabilities | 17,600 | 20,000 | 20,000 | 22,000 | 18,100 |
| TOTAL | $253,500 | $245,800 | $225,900 | $212,900 | $190,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 377,700 | 335,100 | 330,700 | 326,300 | 322,000 |
| Other Non-Current Liabilities | 122,200 | 117,600 | 114,700 | 138,000 | 128,800 |
| TOTAL | $499,900 | $452,700 | $445,400 | $464,300 | $450,800 |
| Total Liabilities | $753,400 | $698,500 | $671,300 | $677,200 | $640,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 95,577 | 95,243 | 94,867 | 94,646 | 94,546 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | -547,400 | -635,800 | -628,500 | -651,000 | -693,300 |
| Other shareholders' equity | -9,300 | -1,700 | 400 | 700 | 1,000 |
| TOTAL | $1,391,100 | $1,374,000 | $1,346,000 | $1,279,200 | $1,205,600 |
| Total Liabilities And Equity | $2,144,500 | $2,072,500 | $2,017,300 | $1,956,400 | $1,846,400 |